Nordson Corporation (NDSN) gains on deeper earnings beat
Nordson Corporation (NDSN) gains after topping both EPS and revenue estimates, with the latest quarter showing stronger sales momentum and record-high earnings in the recent sequence. The deep dive also points to improving segment performance, solid backlog trends, and continued analyst support.
Nordson Corporation (NDSN) reported a clear earnings beat, with EPS of $3.25 topping the $3.09 estimate and revenue of $0.82 billion exceeding the $0.78 billion consensus. The stock rose 1.88% as the results reinforced improving demand, strong segment execution, and continued cash generation. For investors, the print supports the bullish case, though valuation remains an important consideration after the move higher.
Nordson Corporation (NDSN) gains after earnings beat
Nordson Corporation (NDSN) gains 1.88% to $309.92 after reporting EPS of $3.25 against a $3.09 estimate and revenue of $0.82B against a $0.78B estimate. The result gives the industrial machinery company a clear earnings beat, while the latest analyst consensus remains Buy.
Key Takeaways
NDSN earnings exceeded estimates on both measures: EPS was $3.25 versus $3.09 expected, while revenue reached $0.82B versus $0.78B expected.
Revenue increased from $0.74B in the fiscal quarter ended April 30 to $0.82B in the quarter ended July 31. The year-earlier quarterly revenue figure was also $0.74B.
The preceding fiscal Q2 report showed broad operating momentum. Industrial Precision Solutions, Medical and Fluid Solutions, and Advanced Technology Solutions all posted record quarterly sales.
Advanced Technology Solutions stood out with $178M of Q2 sales, 8% organic growth, and a record 27% EBITDA margin. Semiconductor demand and electronics dispense products led that segment.
Prior Q2 management commentary cited an 18% organic increase in backlog, $170M of free cash flow, and a 1.9x leverage ratio. The CFO also set a full-year adjusted tax-rate range of 18% to 19% at that time.
The analyst consensus is Buy, with 13 Buy ratings, 8 Holds, and no Sell ratings. DA Davidson raised its price target to $345 from $335, while Oppenheimer lifted its target to $335 from $325.
The headline result is straightforward. Nordson reported $0.82B in revenue for the fiscal quarter ended July 31, above the $0.78B consensus estimate. EPS of $3.25 also cleared the $3.09 estimate. For an industrial company, beating both sales and earnings estimates matters more than a single cost-control win. It points to demand carrying part of the load.
The revenue trend also improved across recent quarters. Nordson recorded $0.67B in revenue for the quarter ended January 31, $0.74B for the quarter ended April 30, and $0.82B for the quarter ended July 31. The year-earlier figure was $0.74B. That sequence places the latest quarter at the top of the five-quarter revenue record supplied for NDSN.
EPS performance has been similarly firm. The earnings surprise history lists $3.25 against $3.09 for August 2026, $2.86 against $2.82 for May, $2.37 against $2.37 for February, $3.03 against $2.93 for December 2025, and $2.73 against $2.64 for August 2025. The latest result is the highest actual EPS figure in that five-quarter sequence.
The segment picture comes from Nordson's preceding fiscal Q2 report. Industrial Precision Solutions generated $350M in sales, up 10% year over year. Organic growth was 5%, with currency adding 4% and the CapstanAG acquisition adding roughly 1%. EBITDA reached $124M, equal to 35% of sales.
Medical and Fluid Solutions produced $213M in Q2 sales, a 5% year-over-year increase. Organic sales rose 8%, supported by Engineered Fluid Solutions and medical product lines. A medical contract manufacturing divestiture reduced reported sales by roughly 4%. EBITDA was $79M, or 37% of sales, although margins faced pressure from a product start-up headwind in selected interventional medical lines.
Advanced Technology Solutions delivered $178M in Q2 sales, a 10% year-over-year increase and an 8% organic gain. Its $48M of EBITDA represented 27% of sales, up from $40M and 25% of sales in the prior-year quarter. This was the strongest margin result among the three reported segments.
Nordson's prior Q2 company-wide margins reinforce the quality of that growth. Adjusted operating profit rose 11% year over year to $199M, or 27% of sales. EBITDA increased 8% to $235M, equal to 32% of sales. Incremental EBITDA contribution was about 31%, a 300-basis-point improvement from the first quarter.
Several line items also shaped the prior quarter's financial profile. Net interest expense was $22M, down $4M year over year. A pension settlement created a one-time $24M pretax charge, while noncash mark-to-market charges on minority investments totaled $10M. Free cash flow reached $170M, representing 119% conversion of net income after excluding those noncash losses.
That cash generation gives Nordson room to balance reinvestment, acquisitions, debt reduction, dividends, and share repurchases. In Q2, the company invested $10M in capital projects, paid $46M in dividends, repurchased $43M of stock, and reduced net debt by $93M.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
NDSN stock closed at $309.92, up 1.88%. Trading volume was 581,574 shares against an average of 394,840. The regular-session gain gives the earnings beat a constructive initial market response, although a strong company and a strong stock are separate judgments. Nordson's valuation still matters after the price move.
The analyst rating mix remains favorable. Thirteen analysts carry Buy ratings and eight carry Hold ratings, with no Sell or Strong Sell ratings in the current consensus record. That distribution places Nordson in a solid position among industrial technology names, though the eight Holds show that the stock's quality does not eliminate valuation debate.
DA Davidson made the clearest bullish adjustment after the prior Q2 report. On May 26, it raised its price target to $345 from $335 and maintained a Buy rating. The firm cited semiconductor demand and strength in Advanced Technology Solutions.
Oppenheimer also raised its target, moving to $335 from $325 on May 29 while keeping an Outperform rating. Later, Weiss Ratings upgraded Nordson from Hold to Buy on June 29. These actions connect the bullish analyst case to semiconductor exposure, improved order activity, and the company's growth portfolio.
The stock reaction therefore rests on two supports. First, the current NDSN earnings report beat estimates on revenue and EPS. Second, earlier analyst actions already recognized stronger demand in Nordson's higher-growth technology businesses. The market is rewarding execution, but the next phase requires that execution to persist.
Management Commentary: Growth Strategy and Financial Discipline
CEO Sundaram Nagarajan framed the prior Q2 performance as broad rather than dependent on one product line. He pointed to organic growth across all three segments, an expanding backlog, and Nordson's NBS Next operating framework.
"I'm very pleased to report a strong second quarter where all 3 segments contributed to our organic growth performance, surpassing the midpoint expectations of last quarter's sales and earnings guidance." - Sundaram Nagarajan, CEO, Fiscal Q2 2026 Earnings Call
Nagarajan's strategic message also centered on portfolio mix. He said more than 50% of Nordson's portfolio now sits in growth end markets, including semiconductor, electronics, and medical. The CapstanAG acquisition added another precision agriculture platform, with Nordson paying 9x adjusted EBITDA and consolidating facilities in Topeka, Kansas.
"We have been very intentional in building a growth biased portfolio of precision technologies." - Sundaram Nagarajan, CEO, Fiscal Q2 2026 Earnings Call
CFO Daniel Hopgood focused on the balance sheet and the quality of cash generation. Net debt was approximately $1.8B, and leverage had fallen to 1.9x. That figure sat below the low end of Nordson's long-term target range, giving the company acquisition capacity without abandoning shareholder returns.
"Our leverage ratio of 1.9x continues to improve from last year and is now actually below the low end of our long-term target range." - Daniel Hopgood, CFO, Fiscal Q2 2026 Earnings Call
Hopgood also set the prior full-year adjusted tax-rate outlook at 18% to 19%, describing the improvement from earlier guidance as sustainable. That detail matters because Nordson's earnings growth came from both operating leverage and capital deployment. The pension annuitization further reduced long-term obligations without a cash outlay.
"This improved outlook for tax rate is very much sustainable and reflective of our ongoing rate expectations." - Daniel Hopgood, CFO, Fiscal Q2 2026 Earnings Call
Nordson's latest earnings beat strengthens the case for a company combining industrial resilience with faster growth in semiconductor, electronics, medical, and precision agriculture markets. The $0.82B revenue result, $3.25 EPS, strong cash conversion, and Buy consensus support a constructive outlook, while the stock's $309.92 price keeps valuation discipline relevant.
The investment thesis now rests on sustained organic growth, stable margins, and disciplined acquisitions. Nordson has delivered the first part in recent quarters; continued execution will determine whether the current gains develop into durable market leadership.
Yes. Nordson reported EPS of $3.25 versus the $3.09 estimate and revenue of $0.82 billion versus the $0.78 billion estimate. That is a beat on both profit and sales.
+Why did Nordson stock rise after earnings?
NDSN gained 1.88% to $309.92 because the company delivered a stronger-than-expected quarter on both EPS and revenue. The market also reacted positively to the improving revenue trend, which rose from $0.74 billion in the prior quarter to $0.82 billion.
+What were Nordson's latest revenue and EPS results?
Nordson posted revenue of $0.82 billion for the fiscal quarter ended July 31 and EPS of $3.25. Those results exceeded consensus estimates of $0.78 billion in revenue and $3.09 in EPS.
+What is the analyst rating on Nordson (NDSN) after the earnings report?
The analyst consensus remains Buy. The current mix includes 13 Buy ratings, 8 Hold ratings, and no Sell ratings, and several firms raised price targets after the report.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Report
Want the full picture on NDSN?
The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.
